SCHEMBL17486283

SCHEMBL17486283

COc1cc(Br)cnc1-c1ccc2c(c1)C(C)(C)C(C)(C)C2(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
DYRK1B Q9Y463 1/20 0.33
MAPT P10636 5/20 0.32
NPSR1 Q6W5P4 3/20 0.32
ATM Q13315 2/20 0.32
MAPK1 P28482 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CHEK1 O14757 2/20 0.31
RAB9A P51151 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
SLC2A1 P11166 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 2/20 0.31
AKT1 P31749 1/20 0.31
HTT P42858 1/20 0.31
NPC1 O15118 2/20 0.30
SHMT2 P34897 1/20 0.30
GAA P10253 1/20 0.30
ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17486204 0.85 PDGFRB (0.34) IDO1MAPTRAB9AALDH1A1GAA
SCHEMBL19295077 0.83 ALOX5AP (0.33)
SCHEMBL17486288 0.83 DYRK1B (0.34) IDO1TDO2DYRK1BMAPTNPSR1
SCHEMBL17486236 0.82 SMN1; SMN2 (0.35) MAPTNPSR1MAPK1SMN1; SMN2ALDH1A1
SCHEMBL17486219 0.81 ALDH1A1 (0.35) MAPTNPSR1MAPK1SMN1; SMN2ALDH1A1
SCHEMBL17486280 0.80 HTR2C (0.43) IDO1
SCHEMBL17486132 0.78 ALDH1A1 (0.40) IDO1MAPTATMMAPK1L3MBTL1
SCHEMBL19295096 0.78 DGAT1 (0.37)
SCHEMBL17486286 0.77 CYP11B1 (0.35) MAPTNPSR1MAPK1SMN1; SMN2ALDH1A1
SCHEMBL17486017 0.76 SMN1; SMN2 (0.33) DYRK1BRAB9ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 IDO1 2782/4885TDO2 2590/4885DYRK1B 4672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.